3 times higher healthcare cost in chronic hepatitis B patients compared to non-chronic hepatitis B controls especially those with decompensated liver disease: United States real world healthcare utilization and cost analysis Nguyen, M. H., Lim, J., Ozbay, A. B., Shreay, S., Liou, I., Meyer, N., Dusheiko, G., Gordon, S. ELSEVIER SCIENCE BV. 2017: S369–S370

View details for DOI 10.1016/S0168-8278(17)31083-8

View details for Web of Science ID 000401056600820